Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Castillo

Showing results (171-180 of 177) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 177 results.
Microbial Drug Resistance (Larchmont, N.Y.)|July 1, 1997
Distribution of capsular types and antimicrobial susceptibility of invasive isolates of Streptococcus pneumoniae in Colombian children. Pneumococcal Study Group in ColombiaE Castañeda, A L Leal, O Castillo, et al.
ESMO Open|October 17, 2025
Ki67 dynamic predicts endocrine sensitivity in estrogen receptor-positive/HER2-negative breast cancer patients undergoing preoperative endocrine therapyR Gómez-Bravo, B Walbaum, M Bergamino, et al.
Molecular Genetics and Metabolism|February 4, 2018
Prenatal treatment of ornithine transcarbamylase deficiencyYael Wilnai, Yair J Blumenfeld, Kristina Cusmano, et al.
ESMO Open|April 10, 2025
Prevalence and clinical impact of germline pathogenic variants in breast cancer: a descriptive large single-center studyA Rodriguez-Hernandez, O Martínez-Sáez, F Brasó-Maristany, et al.
Climacteric : the Journal of the International Menopause Society|June 22, 2016
Does the menopausal status of female gynecologists affect their prescription of menopausal hormone therapy?M S Vallejo, S Witis, E Ojeda, et al.
ESMO Open|October 1, 2025
Efficacy of anti-PD1 therapy in PD1-high mRNA tumors across multiple cancer types: results from cohort 1 and cohort 2 of the phase II SOLTI-1904 ACROPOLI trialE Seguí, F Brasó-Maristany, T Pascual, et al.
ESMO Open|March 7, 2024
Analytical validation of HER2DX genomic test for early-stage HER2-positive breast cancerM Marín-Aguilera, P Jares, E Sanfeliu, et al.
Pageof 18

Showing results (171-180 of 177) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 177 results.
Microbial Drug Resistance (Larchmont, N.Y.)|July 1, 1997
Distribution of capsular types and antimicrobial susceptibility of invasive isolates of Streptococcus pneumoniae in Colombian children. Pneumococcal Study Group in ColombiaE Castañeda, A L Leal, O Castillo, et al.
ESMO Open|October 17, 2025
Ki67 dynamic predicts endocrine sensitivity in estrogen receptor-positive/HER2-negative breast cancer patients undergoing preoperative endocrine therapyR Gómez-Bravo, B Walbaum, M Bergamino, et al.
Molecular Genetics and Metabolism|February 4, 2018
Prenatal treatment of ornithine transcarbamylase deficiencyYael Wilnai, Yair J Blumenfeld, Kristina Cusmano, et al.
ESMO Open|April 10, 2025
Prevalence and clinical impact of germline pathogenic variants in breast cancer: a descriptive large single-center studyA Rodriguez-Hernandez, O Martínez-Sáez, F Brasó-Maristany, et al.
Climacteric : the Journal of the International Menopause Society|June 22, 2016
Does the menopausal status of female gynecologists affect their prescription of menopausal hormone therapy?M S Vallejo, S Witis, E Ojeda, et al.
ESMO Open|October 1, 2025
Efficacy of anti-PD1 therapy in PD1-high mRNA tumors across multiple cancer types: results from cohort 1 and cohort 2 of the phase II SOLTI-1904 ACROPOLI trialE Seguí, F Brasó-Maristany, T Pascual, et al.
ESMO Open|March 7, 2024
Analytical validation of HER2DX genomic test for early-stage HER2-positive breast cancerM Marín-Aguilera, P Jares, E Sanfeliu, et al.
Pageof 18